These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


374 related items for PubMed ID: 22781222

  • 1. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
    Peters L, Grint D, Lundgren JD, Rockstroh JK, Soriano V, Reiss P, Grzeszczuk A, Sambatakou H, Mocroft A, Kirk O, EuroSIDA in EuroCoord.
    AIDS; 2012 Sep 24; 26(15):1917-26. PubMed ID: 22781222
    [Abstract] [Full Text] [Related]

  • 2. Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe.
    Ryom L, Kirk O, Lundgren JD, Reiss P, Pedersen C, De Wit S, Buzunova S, Gasiorowski J, Gatell JM, Mocroft A, EuroSIDA in EuroCoord.
    HIV Med; 2013 Sep 24; 14(8):503-8. PubMed ID: 23590641
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
    Tsui JI, Vittinghoff E, Shlipak MG, Bertenthal D, Inadomi J, Rodriguez RA, O'Hare AM.
    Arch Intern Med; 2007 Jun 25; 167(12):1271-6. PubMed ID: 17592100
    [Abstract] [Full Text] [Related]

  • 7. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
    Rasch MG, Engsig FN, Feldt-Rasmussen B, Kirk O, Kronborg G, Pedersen C, Gerstoft J, Obel N.
    Scand J Infect Dis; 2012 Sep 25; 44(9):689-96. PubMed ID: 22680981
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
    Rossi C, Raboud J, Walmsley S, Cooper C, Antoniou T, Burchell AN, Hull M, Chia J, Hogg RS, Moodie EE, Klein MB, Canadian Observational Cohort (CANOC) Collaboration.
    BMC Infect Dis; 2017 Apr 04; 17(1):246. PubMed ID: 28376824
    [Abstract] [Full Text] [Related]

  • 9. Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: a cross-sectional study.
    Lee JJ, Lin MY, Yang YH, Lu SN, Chen HC, Hwang SJ.
    Am J Kidney Dis; 2010 Jul 04; 56(1):23-31. PubMed ID: 20400217
    [Abstract] [Full Text] [Related]

  • 10. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
    Canavese C, Hollò Z, Ciccone G, Ghisetti V, Barbui A, Fop F, Martina G, Forgnone F, Novo P, Thea A, Grill A, Marchiaro G.
    J Nephrol; 2000 Jul 04; 13(5):352-9. PubMed ID: 11063139
    [Abstract] [Full Text] [Related]

  • 11. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD, HepaI.Co.N.A. Study Group, Italian Cohort Naive for Antiretrovirals Study Group.
    Clin Infect Dis; 2005 Jun 15; 40(12):e101-9. PubMed ID: 15909251
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.
    Lucas GM, Jing Y, Sulkowski M, Abraham AG, Estrella MM, Atta MG, Fine DM, Klein MB, Silverberg MJ, Gill MJ, Moore RD, Gebo KA, Sterling TR, Butt AA, NA-ACCORD of the IeDEA.
    J Infect Dis; 2013 Oct 15; 208(8):1240-9. PubMed ID: 23904290
    [Abstract] [Full Text] [Related]

  • 13. Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational Database.
    Cheung J, Puhr R, Petoumenos K, Cooper DA, Woolley I, Gunathilake M, Raymond N, Varma R, O'Connor CC, Gracey DM.
    Nephrology (Carlton); 2018 Aug 15; 23(8):778-786. PubMed ID: 28703924
    [Abstract] [Full Text] [Related]

  • 14. Harmful effects of viral replication in seropositive hepatitis C virus renal transplant recipients.
    Gentil Govantes MA, Esforzado N, Cruzado JM, González-Roncero FM, Balaña M, Saval N, Morales JM.
    Transplantation; 2012 Dec 15; 94(11):1131-7. PubMed ID: 23104249
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care.
    Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, Krishnasami Z, Willig JH, Martin JN, Moore RD, Eron JJ, Kitahata MM.
    AIDS; 2012 Sep 24; 26(15):1907-15. PubMed ID: 22824630
    [Abstract] [Full Text] [Related]

  • 16. Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons.
    Mocroft A, Ryom L, Oprea C, Li Q, Rauch A, Boesecke C, Uzdaviniene V, Sedlacek D, Llibre JM, Lacombe K, Nielsen LN, Florence E, Aho I, Chkhartishvili N, Szlavik J, Dragovic G, Leen C, Sambatakou H, Staub T, Laguno M, Elinav H, Tomažič J, Peters L, EuroSIDA study group.
    AIDS; 2020 Aug 01; 34(10):1485-1495. PubMed ID: 32675562
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and risk factors for chronic kidney disease among HIV-infected antiretroviral therapy-naïve patients in mainland China: a multicenter cross-sectional study.
    Cao Y, Gong M, Han Y, Xie J, Li X, Zhang L, Li Y, Song X, Zhu T, Li T.
    Nephrology (Carlton); 2013 Apr 01; 18(4):307-12. PubMed ID: 23311442
    [Abstract] [Full Text] [Related]

  • 18. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M, Penning M, van Putten M, Lukashov V, van den Hoek A, McMorrow M, Goudsmit J.
    Hepatology; 1999 Apr 01; 29(4):1288-98. PubMed ID: 10094977
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.
    Hepatogastroenterology; 1997 Apr 01; 44(14):417-25. PubMed ID: 9164512
    [Abstract] [Full Text] [Related]

  • 20. Short-term change in kidney function and risk of end-stage renal disease.
    Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, Matsushita K, Hemmelgarn BR.
    Nephrol Dial Transplant; 2012 Oct 01; 27(10):3835-43. PubMed ID: 22764191
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.